(“NetScientific” or the “Company” or the “Group”)
Notice of Results
London, UK – 24 March 2016 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic biomedical and healthcare technology group, announces that it will report its final results for the 12 months ended 31 December 2015 on 07 April 2016.
An analyst presentation will be held at the offices of Consilium Strategic Communications at 41, Lothbury, EC2R 7HG at 12.00 on 07 April 2016.
– Ends –
For more information, please contact:
|
NetScientific François R. Martelet, M.D., CEO Mark Nanovich, Interim CFO
|
Tel: +44 (0)20 3514 1800 |
|
Investec (NOMAD and broker) Gary Clarence / Daniel Adams
|
Tel: +44 (0)20 7597 4000 |
|
Consilium Strategic Communications Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton
|
Tel: +44 (0)20 3709 5700 netscientific@consilium-comms.com |
About NetScientific Plc
NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people’s lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net.
END
NORLFFFLVVIVFIR